CRBP

10.26

1.58% 0.16

Vorhandelsmarkt: 11.43 1.17 +11.40%

Corbus Pharmaceuticals Holdings Inc (CRBP)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$10.10

Offen:

$10.07

24-Stunden-Volumen:

313.14K

Relative Volume:

0.88

Marktkapitalisierung:

$180.09M

Einnahmen:

$1.54M

Nettoeinkommen (Verlust:

$-38.70M

KGV:

-2.197

EPS:

-4.67

Netto-Cashflow:

$-36.86M

1W Leistung:

-3.84%

1M Leistung:

-2.29%

6M Leistung:

+11.04%

1J Leistung:

-36.03%

1-Tages-Spanne:

$9.90

$10.31

1-Wochen-Bereich:

$9.90

$10.82

52-Wochen-Spanne:

$4.64

$20.56

Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Company Profile

Firmenname

Corbus Pharmaceuticals Holdings Inc

Sektor

Healthcare (1124)

Branche

Biotechnology (627)

Telefon

617-963-0103

Adresse

500 RIVER RIDGE DRIVE, NORWOOD, MA

Mitarbeiter

Twitter

@corbuspharma

Nächster Verdiensttermin

2024-11-05

Neueste SEC-Einreichungen

CRBP's Discussions on Twitter

Vergleichen Sie CRBP mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
CRBP Corbus Pharmaceuticals Holdings Inc	10.26	177.29M	1.54M	-38.70M	-36.86M	-4.67
VRTX Vertex Pharmaceuticals Inc	444.64	110.88B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	726.21	72.79B	14.25B	4.58B	3.88B	41.77
ARGX Argen X Se Adr	890.11	54.76B	3.06B	1.28B	447.35M	19.67
ALNY Alnylam Pharmaceuticals Inc	404.46	54.85B	3.21B	43.57M	221.36M	0.2405
INSM Insmed Inc	189.85	41.41B	447.02M	-1.18B	-906.14M	-6.1812

Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-07-30	Fortgesetzt	B. Riley Securities	Buy
2025-02-28	Eingeleitet	William Blair	Outperform
2024-12-02	Eingeleitet	Piper Sandler	Overweight
2024-07-30	Eingeleitet	Wedbush	Outperform
2024-07-22	Fortgesetzt	H.C. Wainwright	Buy
2024-06-26	Eingeleitet	B. Riley Securities	Buy
2024-06-03	Bestätigt	Oppenheimer	Outperform
2024-05-13	Eingeleitet	RBC Capital Mkts	Outperform
2024-03-06	Hochstufung	Jefferies	Hold → Buy
2020-09-08	Herabstufung	BTIG Research	Buy → Neutral
2020-09-08	Herabstufung	Jefferies	Buy → Hold
2020-09-08	Herabstufung	RBC Capital Mkts	Outperform → Sector Perform
2020-09-08	Herabstufung	ROTH Capital	Buy → Neutral
2020-07-07	Eingeleitet	ROTH Capital	Buy
2020-06-17	Eingeleitet	BTIG Research	Buy
2020-03-26	Eingeleitet	Nomura	Buy
2019-04-05	Eingeleitet	Jefferies	Buy
2019-03-20	Eingeleitet	Oppenheimer	Outperform
2019-01-11	Bestätigt	Cantor Fitzgerald	Overweight
2018-12-26	Eingeleitet	H.C. Wainwright	Buy
2018-12-07	Eingeleitet	RBC Capital Mkts	Outperform
2018-10-24	Eingeleitet	B. Riley FBR	Buy
2018-01-19	Eingeleitet	Raymond James	Outperform
2017-12-14	Bestätigt	Cantor Fitzgerald	Overweight
2017-11-08	Bestätigt	Noble Financial	Buy
2017-09-29	Fortgesetzt	Noble Financial	Buy
2017-03-30	Bestätigt	Cantor Fitzgerald	Overweight
2016-11-15	Bestätigt	JMP Securities	Mkt Outperform
2016-11-11	Bestätigt	Noble Financial	Buy

Alle ansehen

Corbus Pharmaceuticals Holdings Inc Aktie (CRBP) Neueste Nachrichten

Dec 10, 2025

Corbus to release phase 1a study results for obesity drug CRB-913 - Investing.com

Dec 10, 2025

Corbus Pharmaceuticals to Announce Phase 1a Results for CRB-913 on December 11, 2025 - Quiver Quantitative

Dec 10, 2025

Corbus Pharmaceuticals (NASDAQ: CRBP) to release Phase 1a CRB-913 obesity data on Dec. 11 - Stock Titan

Dec 10, 2025

Dec 05, 2025

Will Corbus Pharmaceuticals Holdings Inc. stock remain a Wall Street favoriteMarket Sentiment Summary & Free Weekly Chart Analysis and Trade Guides - Newser

Dec 05, 2025

Why Corbus Pharmaceuticals Holdings Inc. (3371) stock trades below fair valueInsider Selling & Free Expert Verified Stock Movement Alerts - Newser

Dec 05, 2025

Dec 04, 2025

Why Corbus Pharmaceuticals Holdings Inc. (3371) stock attracts wealthy investorsEntry Point & Advanced Technical Signal Analysis - Newser

Dec 04, 2025

What risks investors should watch in Corbus Pharmaceuticals Holdings Inc. stock2025 AllTime Highs & Intraday High Probability Alerts - Newser

Dec 04, 2025

Is Corbus Pharmaceuticals Holdings Inc. (3371) stock a top dividend aristocrat candidate2025 Big Picture & Real-Time Volume Surge Alerts - Newser

Dec 04, 2025

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Dec 04, 2025

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World

Dec 04, 2025

Dec 03, 2025

Is Corbus Pharmaceuticals Holdings Inc. (3371) stock bottoming after sell offStop Loss & Free Weekly Watchlist of Top Performers - Newser

Dec 03, 2025

Corbus Pharmaceuticals (CRBP) Stock Analysis Report | Financials & Insights - Benzinga

Dec 03, 2025

Dec 02, 2025

Corbus Pharmaceuticals Holdings Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Dec 02, 2025

Behavioral Patterns of CRBP and Institutional Flows - news.stocktradersdaily.com

Dec 02, 2025

Why Corbus Pharmaceuticals Holdings Inc. (3371) stock could be top winnerForecast Cut & AI Driven Stock Movement Reports - Newser

Dec 02, 2025

Dec 01, 2025

Corbus Pharmaceuticals Holdings Inc. stock underperforms Monday when compared to competitors - MarketWatch

Dec 01, 2025

B. Riley Forecasts Lower Earnings for Corbus Pharmaceuticals - MarketBeat

Dec 01, 2025

Nov 28, 2025

Corbus Pharmaceuticals Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch

Nov 28, 2025

What analysts say about Corbus Pharmaceuticals Holdings Inc 3371 stockSector Performance Drivers & Free Trading Psychology Sessions - earlytimes.in

Nov 28, 2025

What is B. Riley’s Forecast for CRBP FY2029 Earnings? - Defense World

Nov 28, 2025

Nov 25, 2025